Jennifer Brown, NP
Women's Health · Indianapolis, INNPI 1396835401
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $587 of the $672 with a category attached, or 87.4%. It is spread thinly across 11 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations.
Across 22 payments — averaging $30.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$144
- Exeltis, USA Inc.$117
- Astellas Pharma US Inc$100
- Paratek Pharmaceuticals, Inc.$78
- AbbVie$77
- Ironshore Pharmaceuticals Inc.$44
- plus $112 from 5 others
What the payments were for
- Food & beverage$58787%
- Education$8513%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 1 | $144 |
| Exeltis, USA Inc. | 2 | $117 |
| Astellas Pharma US Inc | 2 | $100 |
| Paratek Pharmaceuticals, Inc. | 5 | $78 |
| AbbVie | 4 | $77 |
| Ironshore Pharmaceuticals Inc. | 3 | $44 |
| Convatec Inc. | 1 | $35 |
| Biogen | 1 | $22 |
| Myovant Sciences Inc. | 1 | $20 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REZUROCK$144
How this compares
$672 in reported general payments places this provider in the 70th percentile of 142 women's health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $497 |
| Estradiol (Twice Weekly)Estradiol | 11 | $353 |
| Paroxetine Hcl | 13 | $66 |
Paid to pharmacies, not to this prescriber.
Other women's health in Indianapolis
- Cara RaunickIndianapolis$73K
- Courtney CortezIndianapolis$5K
- Kesha KellyIndianapolis$4K
- Lara NaanouhIndianapolis$2K
- Susan LogsdonIndianapolis$2K
- Lisa Chan OwensbyIndianapolis$1K
- Ninya WilkersonIndianapolis$687
- Kara MortonIndianapolis$622
- Lauren ThorntonIndianapolis$570
- Jordan RamirezIndianapolis$561
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.